HealthEquity, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HQY research report →
Range $108 – $142
Price Chart
About the company
Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings.
- CEO
- Scott R. Cutler
- IPO
- 2014
- Employees
- 2,814
- HQ
- Draper, UT, US
Get TickerSpark's AI analysis on HQY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.84B
- P/E
- 36.37
- Fwd P/E
- 20.06
- PEG
- 0.55
- P/S
- 6.18
- P/B
- 4.27
- EV/EBITDA
- 18.46
- Div Yield
- 0.00%
- Gross Margin
- 75.21%
- Op Margin
- 25.61%
- Net Margin
- 17.36%
- ROE
- 11.43%
- ROIC
- 8.55%
Latest fiscal year · YoY change
- Revenue
- $1.31B+9.5%
- Gross Profit
- $913.12M+31.8%
- Op Income
- $322.46M
- Net Income
- $215.20M+122.5%
- EPS
- $2.50+125.2%
- OCF Growth
- +34.5%
- FCF Growth
- +34.7%
- 52W High
- $110.26
- 52W Low
- $72.76
- 50D MA
- $96.57
- 200D MA
- $90.29
- Beta
- 0.22
- RSI (14)
- 39
- Avg Volume
- 884.56K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
HealthEquity reported accelerated Q2 revenue growth, record margins, and record HSA account/asset metrics, then raised full-year fiscal 2027 guidance.· August 27, 2026
- Revenue grew 8% year over year, with record service revenue of $124.4 million and record custodial revenue of $175.9 million.
- Adjusted EBITDA reached a record $167 million, and adjusted EBITDA margin expanded to 48% from 46% last year.
- HSA assets rose 14% year over year, total HSAs grew 8%, and new HSAs from sales increased 24% year over year.
- Marketplace and investing engagement continued to build, with more than 14,000 active Marketplace members and record investing HSA member penetration of 20%.
- Management raised fiscal 2027 guidance and said the model is becoming more durable through AI-enabled efficiency, better service, and stronger cash flow.
Second-quarter revenue increased 8% year over year. Service revenue was a record $124.4 million, up 6%; custodial revenue was a record $175.9 million, up 10%; and interchange revenue was $50.4 million, up 5%. Gross profit was a record $258 million, or approximately 74% of revenue, versus 71% in the second quarter last year. GAAP net income was a record $65.6 million, or $0.78 per diluted share; non-GAAP net income was $103.8 million, or $1.24 per diluted share; and adjusted EBITDA was a record $167 million, up 11% year over year, with adjusted EBITDA margin at 48% versus 46% last year. For the first six months, revenue was $705.4 million, up 7%; GAAP net income was $135.1 million, or $1.60 per diluted share; non-GAAP net income was $208.9 million, or $2.47 per diluted share; and adjusted EBITDA was $331.5 million, up 14%, with 47% margin. HSA assets were up 14% year over year, total HSAs grew 8%, new HSAs from sales grew 24%, and HSA accounts reached a record 10.7 million. The company ended the quarter with $256 million in cash, generated $136 million of operating cash flow, had about $931 million of debt net of issuance costs, and repurchased about $108 million of shares at an average price below $90. Full-year fiscal 2027 guidance was raised to revenue of $1.411 billion to $1.421 billion, GAAP net income of $242 million to $248 million, non-GAAP net income of $392 million to $398 million, and adjusted EBITDA of $628 million to $636 million. The company now expects average HSA cash yield to be between 3.85% and 3.9% for fiscal 2027.
Scott Cutler framed the quarter as proof that the model is not only scaling but becoming more durable, citing stronger operating cash flow, disciplined capital allocation, and record profitability. He emphasized three growth drivers: account and asset growth, deeper member engagement through the app/Marketplace/investing, and technology- and AI-enabled efficiency that lowers service costs. His tone was confident and expansionary, with repeated comments that the company is still early in Marketplace, app integration, and AI-driven workflow automation.
James Lucania focused on the financial acceleration and margin build: revenue up 8%, gross profit at 74% of revenue, adjusted EBITDA margin at 48%, and record GAAP/non-GAAP earnings. He noted that service costs continued to fall on a per-account basis while total accounts grew 4%, and said there was no unusual item in the service cost line beyond a $3.3 million one-time disposal expense related to unused internally developed software. He also highlighted balance sheet flexibility, with $256 million of cash, $136 million of operating cash flow, about $931 million of debt, about $948 million remaining under the repurchase authorization, and guidance that includes continued buybacks, possible revolver paydown, and funding growth initiatives.
Analysts focused on Marketplace traction, interchange revenue, margin sustainability, HSA cash yield, and whether stronger demand was being driven by affordability concerns in healthcare. Management said Marketplace traffic, subscriber growth, and conversion are improving, with Health Savings Days producing the highest traffic and largest sales week in Marketplace history and 500,000 unique visitors in one week; they also said Marketplace is not yet material to company revenue but is an important engagement signal. On margins, management said the improvement is being driven by AI, automation, and lower service costs, and that there is still more room to improve as AI expands into client and back-office workflows. On cash yield and custodial revenue, management said the yield outlook is tight because much of the cash is already hedged, and that higher five-year Treasury rates help over time but do not immediately flow through due to the hedge structure. On healthcare affordability, management said it is a major tailwind as employers seek ways to lower annual cost growth, and they cited more adoption of HDHP/HSA structures, ICHRA interest, and broader individual-market opportunities.
The call showed multiple signs of operating leverage: revenue accelerated, margins hit records, operating cash flow strengthened, and management raised full-year guidance. Management also described durable demand drivers beyond new account adds, including strong renewals, faster sales growth, rising investing adoption, and early Marketplace engagement that may expand member lifetime value over time.
Management acknowledged the business still faces a competitive market, headline price erosion, and the need to share some savings back with clients, which can pressure service revenue. They also said Marketplace revenue is still immaterial today, HSA cash yield benefits are limited near term because much of the portfolio is already hedged, and some of the margin gains are early-stage and not yet fully proven across client and back-office workflows.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.9%
- Shares Outstanding
- 82.72M
- Float Shares
- 80.97M
of shares held by institutions
512 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for HQY, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Gilbert CisnerosHouse · CA31 | Buy | Jul 10, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Jun 30, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | May 29, 26 | Filing → |
| Lisa C. McClainHouse · MI09 | Buy | Jun 11, 25 | Filing → |
| Lisa C. McClainHouse · MI09 | Sell | Jun 17, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Jun 16, 25 | Filing → |
| Robert P. BresnahanHouse · PA08 | Sell | Jan 13, 25 | Filing → |
| Josh GottheimerHouse · NJ05 | Sell | Nov 7, 24 | Filing → |
| Josh GottheimerHouse · NJ05 | Sell | Jun 21, 24 | Filing → |
| Blake D. MooreHouse · UT01 | Sell | Jan 19, 24 | Filing → |
| Daniel GoldmanHouse · NY10 | Sell | Apr 10, 23 | Filing → |
| Josh GottheimerHouse · NJ05 | Buy | Jan 10, 22 | Filing → |
| Josh GottheimerHouse · NJ05 | Sell | Dec 9, 21 | Filing → |
| Blake D. MooreHouse · UT01 | Buy | May 11, 21 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 11.30M | ▲ 23.41K |
| Vanguard Group Inc | 8.67M | ▼ 77.72K |
| Wasatch Advisors LP | 7.01M | ▼ 949.27K |
| Vanguard Portfolio Management LLC | 3.95M | ▼ 105.74K |
| Morgan Stanley | 3.81M | ▼ 740.62K |
| Vanguard Capital Management LLC | 3.58M | ▼ 65.73K |
| State Street Corp | 3.24M | ▲ 1.17K |
| Geode Capital Management, LLC | 2.33M | ▼ 46.91K |
| Dimensional Fund Advisors LP | 1.90M | ▲ 27.78K |
| William Blair Investment Management, LLC | 1.74M | ▼ 33.15K |
| Arrowstreet Capital, Limited Partnership | 1.51M | ▲ 547.95K |
| Price T Rowe Associates Inc | 1.46M | ▲ 463.74K |
Held by 479 ETFs
Biggest fund positions in HQY by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 8, 26 | Rajasekar Sunil | buy | 23 |
| Oct 15, 26 | Rajasekar Sunil | buy | 108 |
| Apr 22, 26 | Rajasekar Sunil | sell | 23 |
| Aug 24, 26 | Rajasekar Sunil | sell | 108 |
| Oct 6, 26 | Ladd Delano | other | 1,080 |
| Oct 6, 26 | Fiore Michael Henry | other | 2,032 |
| Oct 6, 26 | Neeleman Stephen | other | 1,095 |
| Oct 6, 26 | Gathright Michael | other | 662 |
| Oct 6, 26 | Lucania James M | other | 2,822 |
| Oct 6, 26 | Cutler Scott | other | 1,230 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HQY coverage
Recent articles, reports, and earnings notes.
No research on HQY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HQY report →Here's Why HealthEquity (HQY) is a Strong Value Stock
zacks.com · Nov 20
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
zacks.com · Nov 18
Reasons to Add HealthEquity Stock to Your Portfolio for Now
zacks.com · Nov 6
HealthEquity Schedules Third Quarter Earnings Release Date
globenewswire.com · Nov 3
BLCO vs. HQY: Which Stock Is the Better Value Option?
zacks.com · Nov 3
Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes"
zacks.com · Oct 28
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
zacks.com · Oct 15
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
zacks.com · Oct 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.